SensArs Neuroprosthetics Wins €3 Million European Funding to Refine its Sensation-Giving Leg Prosthesis
08.10.2019
SensArs will lead the GoSafe project group that includes Ossur, the world's second-largest prosthesis manufacturer, and clinical centers in Italy and Germany. Co-founder and CEO, Francesco Petrini, recalls his early kicks with Venture Kick.
 |
 |
Patients using its prosthesis walk faster, with less body and mental fatigue, greater stability, and reduced instance of phantom limb pain, Lausanne-based SensArs' stated. SensArs won CHF 130,000, training and support from Venture Kick in 2017.
"Venture Kick helped improving the way we pitch, and shaping our business case. Venture Kick challenged our assumptions and helped us making them more realistic," said SensArs Neuroprosthetics' co-founder and CEO, Francesco Petrini.
What is SensArs' mission and core innovation?
SensArs's mission is to restore lost sensory-motor functions to people with amputation or damaged peripheral nerves. Our core innovation is an implantable electrode for peripheral nerves. This new electrode crosses the nerve maximizing the efficiency of communication with the nerve.
How will this 3-million-euro-funding help you achieve your vision?
“We received the financing as part a consortium alongside two clinical centers -- the Policlinico Gemelli in Rome, and Charité in Berlin -- and Icelandic prosthesis manufacturer Ossur. Coordinating the consortium SensArs will develop the industrial prototype of its product, SENSY, with the assistance of Ossur, for Policlinico Gemelli and Charité to then conduct clinical trials with leg amputees with the aim of obtaining evidence for CE marking.
